J Rheumatol:心血管合并症和糖尿病对手部骨关节炎、疼痛和功能状态转变的影响

2020-03-01 xiangting MedSci原创

总的来说,随时间推移,患有或新出现DM和/或CVD会降低症状和功能改善的可能性,这提示CVD和DM合并症对HOA的临床和放射学病程有影响。

这项研究目的是探讨手部骨关节炎(HOA)的病程及其与心血管疾病(CVD)和糖尿病DM)的关系。

3个时间点收集来自845名约翰斯顿县骨关节炎项目参与者的数据(2/3为女性,1/3为非裔美国人,平均年龄60岁),这些患者伴或不伴HOACVDDM。放射学手部骨关节炎(rHOA)的诊断需要每只手至少3个关节Kellgren-Lawrence严重度分级≥2。四态渐进模型包括基于rHOA的转变和使用澳大利亚/加拿大手部骨关节炎指数(AUSCAN)定义的疼痛或功能。调整基线和时变协变量后,使用马尔可夫多状态模型估算了DMCVD与特定状态转换之间相关性的风险比和95%置信区间(aHR [95])。

患有DM的参与者(与无DM参与者比较)更容易出现rHOA疼痛加重。无论rHOA状态如何,伴CVD的患者(与无CVD患者比较)症状改善的可能性明显降低。尽管只有伴DM和无rHOA的患者具有统计学显著性,伴DMCVD的患者(与没有这些合并症的患者比较)功能改善的可能性较小。

总的来说,随时间推移,患有或新出现DM/CVD会降低症状和功能改善的可能性,这提示CVDDM合并症对HOA临床和放射学病程有影响。需要进一步的研究来证实这些发现。

原始出处:

Zachary A. Scherzer. Effects of Comorbid Cardiovascular Disease and Diabetes Mellitus on Hand Osteoarthritis, Pain, and Functional State Transitions. J Rheumatol. February 2020.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1825879, encodeId=3b0818258e943, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Dec 01 07:16:00 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693113, encodeId=c6de169311327, content=<a href='/topic/show?id=8b415458e69' target=_blank style='color:#2F92EE;'>#手部骨关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54587, encryptionId=8b415458e69, topicName=手部骨关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=913b29340103, createdName=shizhenshan, createdTime=Fri Jun 05 17:16:00 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026665, encodeId=e818202666537, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Wed Oct 14 18:16:00 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266120, encodeId=7a4a126612068, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622933, encodeId=7d8d162293361, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042988, encodeId=b6ff104298873, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Mar 01 16:16:00 CST 2020, time=2020-03-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1825879, encodeId=3b0818258e943, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Dec 01 07:16:00 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693113, encodeId=c6de169311327, content=<a href='/topic/show?id=8b415458e69' target=_blank style='color:#2F92EE;'>#手部骨关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54587, encryptionId=8b415458e69, topicName=手部骨关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=913b29340103, createdName=shizhenshan, createdTime=Fri Jun 05 17:16:00 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026665, encodeId=e818202666537, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Wed Oct 14 18:16:00 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266120, encodeId=7a4a126612068, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622933, encodeId=7d8d162293361, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042988, encodeId=b6ff104298873, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Mar 01 16:16:00 CST 2020, time=2020-03-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1825879, encodeId=3b0818258e943, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Dec 01 07:16:00 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693113, encodeId=c6de169311327, content=<a href='/topic/show?id=8b415458e69' target=_blank style='color:#2F92EE;'>#手部骨关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54587, encryptionId=8b415458e69, topicName=手部骨关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=913b29340103, createdName=shizhenshan, createdTime=Fri Jun 05 17:16:00 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026665, encodeId=e818202666537, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Wed Oct 14 18:16:00 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266120, encodeId=7a4a126612068, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622933, encodeId=7d8d162293361, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042988, encodeId=b6ff104298873, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Mar 01 16:16:00 CST 2020, time=2020-03-01, status=1, ipAttribution=)]
    2020-10-14 lisa438
  4. [GetPortalCommentsPageByObjectIdResponse(id=1825879, encodeId=3b0818258e943, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Dec 01 07:16:00 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693113, encodeId=c6de169311327, content=<a href='/topic/show?id=8b415458e69' target=_blank style='color:#2F92EE;'>#手部骨关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54587, encryptionId=8b415458e69, topicName=手部骨关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=913b29340103, createdName=shizhenshan, createdTime=Fri Jun 05 17:16:00 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026665, encodeId=e818202666537, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Wed Oct 14 18:16:00 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266120, encodeId=7a4a126612068, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622933, encodeId=7d8d162293361, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042988, encodeId=b6ff104298873, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Mar 01 16:16:00 CST 2020, time=2020-03-01, status=1, ipAttribution=)]
    2020-03-03 lmm397
  5. [GetPortalCommentsPageByObjectIdResponse(id=1825879, encodeId=3b0818258e943, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Dec 01 07:16:00 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693113, encodeId=c6de169311327, content=<a href='/topic/show?id=8b415458e69' target=_blank style='color:#2F92EE;'>#手部骨关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54587, encryptionId=8b415458e69, topicName=手部骨关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=913b29340103, createdName=shizhenshan, createdTime=Fri Jun 05 17:16:00 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026665, encodeId=e818202666537, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Wed Oct 14 18:16:00 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266120, encodeId=7a4a126612068, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622933, encodeId=7d8d162293361, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042988, encodeId=b6ff104298873, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Mar 01 16:16:00 CST 2020, time=2020-03-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1825879, encodeId=3b0818258e943, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Dec 01 07:16:00 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693113, encodeId=c6de169311327, content=<a href='/topic/show?id=8b415458e69' target=_blank style='color:#2F92EE;'>#手部骨关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54587, encryptionId=8b415458e69, topicName=手部骨关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=913b29340103, createdName=shizhenshan, createdTime=Fri Jun 05 17:16:00 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026665, encodeId=e818202666537, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Wed Oct 14 18:16:00 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266120, encodeId=7a4a126612068, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622933, encodeId=7d8d162293361, content=<a href='/topic/show?id=abff3292584' target=_blank style='color:#2F92EE;'>#功能状态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32925, encryptionId=abff3292584, topicName=功能状态)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Mar 03 04:16:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042988, encodeId=b6ff104298873, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Mar 01 16:16:00 CST 2020, time=2020-03-01, status=1, ipAttribution=)]
    2020-03-01 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Esperion的ATP柠檬酸裂解酶抑制剂Nexletol,获FDA批准治疗心血管疾病

美国生物制药公司Esperion的ATP柠檬酸裂解酶(ACL)抑制剂Nexletol(bempedoic acid),获得FDA批准用作动脉粥样硬化性心血管疾病(ASCVD)或杂合家族性高胆固醇血症(HeFH)患者他汀类药物的补充疗法。

Lancet:慢性肾病疾病负担研究——1990-2017

研究发现,全球范围内肾病负担仍十分沉重,是全球死亡及心血管死亡的重要因素

Diabetes Care:1型糖尿病患者脂蛋白(a)与心血管疾病患病率和代谢状态的关系

由此可见,Lp(a)是1型糖尿病患者大血管疾病、蛋白尿和钙化主动脉瓣膜疾病的重要危险因素。1型糖尿病患者的代谢控制不佳与Lp(a)水平升高有关。

Circulation:二十碳五烯酸乙基治疗心血管疾病的疗效的种族差异

一些试验发现,来自美国的患者获益比来自美国之外的患者要少。本预定的REDUCE-IT亚组分析被用来明确二十碳五烯酸乙基在美国的受益程度。REDUCE-IT试验将8179位他汀类药物治疗的甘油三酯≥135并<500 mg/dL、低密度脂蛋白>40并≤100 mg/dL、有动脉硬化或糖尿病病史的患者随机分至实验组(二十碳五烯酸乙基,4 g/d)或安慰剂组。主要复合结点包括心血管死亡、非致死

Hypertension:早产孕妇30年后心血管疾病风险如何?

由此可见,研究人员得出的结论表明妊娠期间的血管疾病,特别是先兆子痫,可以解释早产与未来孕妇心血管疾病住院之间四分之一的关联。

Heart:中国心血管疾病的二级预防

由此可见,中国目前对CVD二级预防药物的使用并不理想,并且在不同人群中差异很大。该研究确定了可扩展的、量身定制干预措施的目标人群,以改善CVD的二级预防。